
Everbright
Asia, Hong Kong Island, Hong Kong, Wan Chai'/%3e%3cuse xlink:href='%23a' transform='rotate(144 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(216 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(288 450 300)'/%3e%3c/svg%3e)
Description
Everbright is China’s cross-border investment and asset management company.
Investor Profile
Everbright has backed more than 11 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 9 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Private Equity, Series C rounds (top funding stages).
- Majority of deals are located in China, United States, Hong Kong.
- Strong thematic focus on Health Care, Manufacturing, Biotechnology.
Stage Focus
- Series A (36%)
- Private Equity (18%)
- Series C (18%)
- Series D (9%)
- Series Unknown (9%)
- Series B (9%)
Country Focus
- China (73%)
- United States (18%)
- Hong Kong (9%)
Industry Focus
- Health Care
- Manufacturing
- Biotechnology
- Medical
- Logistics
- Real Estate
- Real Estate Investment
- Warehousing
- Fintech
- Internet
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.